Abstract
Asthma treatment is evolving as we enter the 21st century. This review focuses on several different areas of asthma treatment now in evolution. These include: (1) the proper role of various asthma controllers—either already approved or under investigation—besides inhaled corticosteriods in asthma therapy; (2) the potential role for immune and cytokine modulation for asthma therapy; (3) the potential role for pharmacogenetics in asthma therapy; and (4) whether single-inhaler therapy with a combination of an inhaled cortcosteriod and a longacted β-agonist could be used for both maintenance and rescue in patients with asthma.
Similar content being viewed by others
References
Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. NIH publication no. 95–3659, January 1995.
National asthma education and prevention program. Expert panel report 2. Guidelines for the diagnosis and management of asthma. NIH publication no. 97–4051, April 1997.
National asthma education and prevention program. Executive summary of the NAEPP expert panel report. Guidelines for the diagnosis and management of asthma—update on selected topics 2002. NIH publication no. 02-5075, June 2002.
Fish, J.E., Kemp J.P., Lockey, R.F., Glass, M., Hanby, L.A., Bonuccelli, C.M., and the Zafirlukast Trialist Group. (1997), Clin Ther 19, 675–690.
Malstrom, K., Rodriguez-Gomez, G., Guerra, J., et al. for the Montelukast/Beclomethasone Study Group. (1999), Ann Intern Med 130, 487–495.
Kemp, J.P., Minkwitz, M.C., Bonuccelli, C.M., and Warren, M.S. (1999), Chest 115, 336–342.
Drazen, J.M., Israel, E., and O’Byrne, P.M. (1999), N Engl J Med 340, 197–206.
Busse, W., Raphael, G.D., Galant, S., et al. for the Fluticasone Propionate Clinical Research Study Group. (2001), J Allergy Clin Immunol 107, 461–468.
Meltzer, E.O., Lockey, R.F., Friedman, B.F., et al. for the Fluticasone Propionate Clinical Research Group. (2002), Mayo Clin Proc 77, 437–445.
Laviolette, M., Malmstrom, K., Lu, S., et al. for the Montelukast/Beclomethasone Additivity group. (1999), Am J Respir Crit Care Med 160, 1862–1868.
Virchow J.C., Jr., Prasse, A., Naya, I., Summerton, L., Harris, A., and the Zafirlukast Study Group. (2000), Am J Respir Crit Care Med 162, 578–585.
Tamaoki, J., Kondo, M., Sakai, N., et al. on behalf of the Tokyo Joshi-Idai Asthma Research Group. (1997), Am J Respir Crit Care Med 158, 1235–1240.
Lofdahl, C.G., Reiss, T.F., Leff, J.A., et al. (1999), BMJ 319, 87–90.
Dahlen, S.-E., Malmstrom, K., Nizankowska, E., et al. (2002), Am J Respir Crit Care Med 165, 9–14.
Villaran, C., O’Neill, S.J., Helbling, A., et al. (1999), J Allergy Clin Immunol 104, 547–553.
Edelman, J.M., Turpin, J.A., Bronsky, E.A., et al. (2000), Ann Intern Med 132, 97–104.
Meltzer, E.O., Malmstron, K., Lu, S., et al. (2000), Allergy Clin Immunol 105, 917–922.
Philip, G., Malmstrom, K., Hampel, F.C., Jr., et al. for the Montelukast Spring Rhinitis Study Group. (2002), Clin Exp Allergy 32, 1020–1028.
Greening, A.P., Ind, P.W., Northfield, M., and Shaw, G. (1994), Lancet 344, 219–223.
Woolcock, A., Lundback, B., Ringdal, N., and Jacques, L.A. (1996), Am J Respir Crit Care Med 153, 1481–1488.
Oauwels, R.A., Lofdahl, C.G., Postma, D.S., et al. (1997), N Engl J Med 337, 1405–1411.
Fish, J.E., Israel, E., Murray, J.J., et al. (2001), Chest 120, 423–430.
Verberne, A.A., Frost, C., Duiverman, E.J., Grol, M.H., and Kerrebijn, K.F. (1998), Am J Respir Crit Care Med 158, 213–219.
Bisgaard, H. (2000), Ped Pulmonol 29, 221–234.
Burrows, B. and Lebowitz, M.D. (1992), N Engl J Med 326, 560,561.
Finkelstein, F.N. (1994), N Engl J Med 331, 1314.
Mclvor, R.A., Pizzichini, E., Turner, M.O., Hussack, P., Hargreave, F.E., and Sears, M.R. (1998), Am J Respir Crit Care Med 158, 924–930.
Williams, C., Crossland L., Finnerty, J., et al. (1998), Thorax 53, 7–13.
Lazarus, S.C., Boushey, H.A., Fahy, J.V., et al. for the Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. (2001), JAMA 285, 2583–2393.
Rickard, K.A. Letter to Physicians. (2003).
Mann M., Chowdhury B., Sullivan, E., Nicklas, R., Anthracite, R., and Meyer, R.J. (2003), Chest 124, 70–74.
Drazen, J.M., Israel, E., Boushey, H.A., et al. for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. (1996), N Engl J Med 335, 841–847.
Spina, D. (2003), Curr Opin Pulm Med 9, 57–64.
Huang, Z., Ducharme, Y., Macdonald, D., and Robichaud, A. (2001), Curr Opin Chem Biol 5, 432–438.
Sturton, G., and Fitzgerald, M. (2002), Chest 121, 192S-196S.
Middleton, O. DowJones Newswires 09-05-03, 04:17 pm EST.
Richwine, L. Reuters Friday September 5, 2003, 4:42 pm EDT.
Bundschuh, D.S., Eltze, M., Barsig, J., Wollin, L., Hatzelmann, A., and Beume, R. (2001), J Pharmacol Exp Ther 297, 280–290.
Boushey, H.A., and Fahy, J.V. (2000), Lancet 356, 2114–2116.
Barnes, P.J. (2000), J Allergy Clin Immunol 106, 5–16.
Borish, L.C., Nelson, H.S., Lanz, M.J., et al. (1999), Am J Respir Crit Care Med 160, 1816–1823.
Borish, L.C., Nelson, H.S., Corren, J., et al. (2001), Allergy Clin Immunol 107, 963–970.
Bryan, S.A., O’Connor, B.J., Matti, S., et al. (2000), Lancet 356, 2149–2153.
Leckie, M.J., ten Brinke, A., Khan, J., et al. (2000), Lancet 356, 2144–2148.
O’Byrne, P.M., Inman, M.D., and Parameswaran, K. (2001), J Allergy Clin Immunol 108, 503–508.
Flood-Page, P.T., Menzies-Cow, A.N., Kay, A.B., and Robinson, D.S. (2003), Am J Respir Crit Care Med 167, 199–204.
Kips, J.C., O’Connor, B.J., Langley, S.J., et al. (2003), Am J Respir Crit Care Med 167, 1655–1659.
Milgrom, H., Fick, R.B., Jr., Su, J.Q., et al. for the rhuMAb-E-25 Study Group. (1999), N Engl J Med 341, 1966–1973.
Soler, M., Matz, J., Twonley, R., et al. (2001), Eur. Respir. J. 18, 254–261.
Busse, W., Corren, J., Lanier, B.Q., et al. (2001), J Allergy Clin Immunol 108, 184–190.
Finn, A., Gross, G., van Bavel, J., et al. (2003), J Allergy Clin Immunol 111, 278–284.
Xolair®, omalizumab product insert (2004), Thompson, Physicians’ Desk Reference, 58th Ed., pp 1374–1376.
Busse, W.W. (2001), Am J Respir Crit Care Med 164, S12-S17.
Rosenwasser, L.J. and Nash, D.B. (2003), Phar Therapeut 28, 400–414.
Babu, K., Arshad, S.H., Wowarth, P.H., et al. (2003), J Allergy Clin Immunol 111, S277 (abstract).
Malmstrom, K., Rodriguez-Gomez, G., Guerra, J., et al. for the montelukast/beclomethasone study group (1999), Ann Intern Med 130, 487–495.
Szefler, S.J., Martin, R.J., King, T.S., et al. for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network (2002), J Allergy Clin Immunol 109, 410–418.
Goldstein, D.B. (2003), N Engl J Med 348, 553–556.
Dewar, J.C., and Hall, I.P. (2003), J Pharm Pharmacol 55, 279–289.
Cooper, R.S., and Psaty, B.M. (2003), Ann Intern Med 138, 576–580.
Lindpainter, K. (2003), J Mol Med 81, 141–153.
Palmer, L.J., Silverman, E.S., Weiss, S.T., and Drazen, J.M. (2002), Am J Respir Crit Care Med 165, 861–866.
Weinshilbourm, R. (2003), N Engl J Med 348, 529–537.
Drazen, J.M., Silverman, E.K., and Lee, T.H. (2000), Br Med Bull 56, 1054–1070.
Israel, E., Drazen, J.M., Liggett, S.B., et al. (2000), Am J Respir Crit Care Med 162, 75–80.
Taylor, D.R., Drazen, J.M., Herbison, G.P., Yandava, C.N., Hancox, R.J., and Town, G.I. (2000), Thorax 55, 762–767.
Drazen, J.M., Yandava, C.N., Dube, L., et al. (1999), Nat Genet 22, 168–170.
In, K.H., Asano, K., Beier, D., et al. (1997), J Clin Invest 99, 1130–1137.
Ind, P. Haughney, J., Price, D., Rosen, J.-P., and Kennelly, J. (2002), Eur. Respir. J. 20(Suppl 38), 41s (abstract).
Haughney, J., Price, D., Rosen, J.-P., and Kennelly, J. (2002), Eur Respir J 20(Suppl 38), 41s (abstract).
Ind, P., Haughney, J., Rosen, J.-P., and Kennelly, J. (2002), Eur Respir J 20 (Suppl 38), 42s (abstract).
Ind, P., Haughney, J., Proce, D., Rosen, J.-P., and Kennelly, J. (2002), Eur Respir J 20(Suppl 38),, 396s (abstract).
Price, D., Haughney, J., Hutchinson, J., and Lloyd, A. (2002), Eur Respir J 20(Suppl 38), 397s (abstract).
Kardos, P., Brueggenjuergen, B., Baare, A. et al. (2002), Eur Respir J 20(Suppl 38), 41s (abstract).
Stallberg, B., Olsson, P., Jorgensen, L.A., Lindarck, N., and Ekstrom, T. (2003), Int J Clin Pract 57, 1–8.
Johansson, G., Stallberg, B., Tornling, G., et al. (2003), Am J Respir Crit Care Med 167, 208 (abstract).
Author information
Authors and Affiliations
Additional information
Supported in part by grants from the Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute HL067663 and HL074225.
Rights and permissions
About this article
Cite this article
Peters, S.P. Asthma treatment in the 21st century. Clinic Rev Allerg Immunol 27, 197–205 (2004). https://doi.org/10.1385/CRIAI:27:3:197
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:27:3:197